Savara
SVRA
#6124
Rank
NZ$1.94 B
Marketcap
NZ$9.49
Share price
-2.79%
Change (1 day)
109.31%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -NZ$0.23 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.21 Billion a decrease over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.23 Billion9.37%
2025 -NZ$0.21 Billion23.94%
2024 -NZ$0.17 Billion75.29%
2023 -NZ$93.16 Million43.38%
2022 -NZ$64.97 Million-11.31%
2021 -NZ$73.26 Million-13.3%
2020 -NZ$84.5 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$56.94 Million34.11%
2016 -NZ$42.46 Million-37.43%
2015 -NZ$67.86 Million38.81%
2014 -NZ$48.88 Million33.62%
2013 -NZ$36.59 Million38.49%
2012 -NZ$26.42 Million24.59%
2011 -NZ$21.21 Million-36.5%
2010 -NZ$33.39 Million-3.14%
2009 -NZ$34.48 Million-23.28%
2008 -NZ$44.93 Million8.52%
2007 -NZ$41.41 Million-34.14%
2006 -NZ$62.87 Million184.43%
2005 -NZ$22.11 Million90.75%
2004 -NZ$11.59 Million190.35%
2003 -NZ$4 Million11.64%
2002 -NZ$3.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.39 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.92 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA